Testagen is a four-amino-acid peptide: lysine, glutamic acid, aspartic acid and glycine, written Lys-Glu-Asp-Gly or KEDG. It comes from Vladimir Khavinson's peptide bioregulator program in St. Petersburg, whose own tables list it as a "regulator of the male reproductive system."[1][2]
That label is where the male-health marketing comes from. We could not find a single study in PubMed that tested Testagen on testicular tissue, testosterone, sperm or fertility, in cells, animals or people. The KEDG papers that do exist are about how the peptide binds DNA, and about thyroid and thymus recovery in chickens, where the authors describe it as a peptide modeled on the pituitary gland.
So Testagen has the thinnest evidence of the bioregulators we cover. Like the rest of the family, what research exists comes from Khavinson's institute and a small circle of collaborators, and none of it has been independently replicated.
- Testagen is the synthetic tetrapeptide Lys-Glu-Asp-Gly (KEDG), listed by Khavinson's group as a male reproductive system regulator.
- No published study has tested it on the testes, testosterone, sperm or fertility (PubMed searched October 2026).
- The published KEDG work covers DNA and histone binding in the lab and thyroid and thymus recovery in chickens with the pituitary gland removed.
- No human trial exists in PubMed or on ClinicalTrials.gov. The "Testagen" trial on ClinicalTrials.gov is an unrelated testosterone spray.
- There is no established dose, and it is not FDA-approved for any use.
| Common Name | Testagen |
| Sequence | Lys-Glu-Asp-Gly (KEDG) |
| Formula / Molecular Weight | C17H29N5O9 / about 447 Da |
| Class | Synthetic short peptide ("peptide bioregulator") |
| Developed by | Khavinson group, St. Petersburg Institute of Bioregulation and Gerontology |
| Primary Research Areas | DNA and histone binding in the lab; thyroid and thymus in pituitary-deficient chickens |
| Male Reproductive Studies | None found in PubMed |
| Human Trials | None found in PubMed or ClinicalTrials.gov |
| FDA Status | Not approved for any indication |
| Forms Sold | 20 mg lyophilized "research" vials |
| Typical Dose | No established dose |
What Is Testagen?
Khavinson's group built a catalog of very short peptides, each assigned to an organ. In its 2022 review, the group lists Testagen (KEDG) as a "regulator of the male reproductive system" and cites no study for that role.[1] Its 2021 systematic review repeats the label.[2]
Check the sequence before you buy or read further. Some vendor and database listings give Testagen other sequences. The one used in the published research, including a 2011 paper that names it, is Lys-Glu-Asp-Gly.[3]
There is also a name collision. A product called "Testagen TDS-Testosterone," a transdermal testosterone spray from a different company, appears on ClinicalTrials.gov in a skin-transfer study (NCT02733133). That product contains testosterone. It has nothing to do with the peptide.
How Does Testagen Work?
The proposed mechanism is the same one Khavinson's group gives for the whole family: short peptides enter the cell and its nucleus and bind DNA or histone proteins, changing which genes are read.[2] For KEDG specifically, what has been measured is:
- Getting into the nucleus. Fluorescently labeled Testagen, Epitalon and Pinealon all entered the cytoplasm, nucleus and nucleolus of HeLa cells, a human cancer cell line.[3]
- Binding DNA. In test-tube experiments, Testagen appeared to bind preferentially to DNA sequences containing CAG, based on how it changed the fluorescence of labeled DNA fragments.[3]
- Binding histones. KEDG and five related peptides bound wheat histone proteins in fluorescence experiments.[4]
- Getting into cells at all. Computer docking ranked KEDG among the better-fitting ligands for the LAT1, LAT2 and PEPT1 transporters that carry small peptides across cell membranes.[5]
None of these experiments involved testicular cells, and none showed which genes KEDG changes in a living animal. The group's differentiation review lists KEDG among peptides that stimulate immune cell differentiation, not reproductive cells.[6]
What the Clinical Evidence Actually Shows
There is no clinical evidence. What exists beyond the lab binding work is a series of studies from a group in Chita, Russia, that has collaborated with Khavinson. In these, KEDG is described as synthesized from the amino acid makeup of extracts from the anterior pituitary gland:
- In chickens whose pituitary gland was removed shortly after hatching, 40 days of KEDG (or its relative Ala-Glu-Asp-Gly) raised thyroid-stimulating hormone and thyroid hormone levels and restored thyroid structure.[7]
- A follow-up in young chickens and old hens found the same normalizing effect, weaker in the old birds.[8]
- A related study reported that the two peptides also normalized immune and blood-clotting measures in these birds.[9]
- In another, KEDG restored thymus structure in pituitary-deficient birds more strongly than Ala-Glu-Asp-Gly.[10]
These are small studies from 2008 to 2013 in an unusual model, and they concern the thyroid and thymus. They say nothing about testosterone.
The only other paper in PubMed that names Testagen in its title is a 2025 chemistry study that tested it as a corrosion inhibitor on copper in salt water, where it reduced corrosion by about 86%.[11] It is a fair measure of how little biological research exists on this peptide.
What the Evidence Does Not Show
- Higher testosterone. No study has measured testosterone after Testagen in any species.
- Leydig or Sertoli cell effects. Vendor descriptions often mention these testicular cells. We found no study testing KEDG on them.
- Fertility or sperm quality. Not studied.
- Benefits for women. Not studied, and nothing in the research suggests a female-specific use.
- Any human effect, safe dose or side effect profile. No human study exists.
Typical Dosing — What the Research Has Used
No established dose
No study in any species has established a Testagen dose for male reproductive health. The figures below describe what circulates online. They are not dosing guidance.
The chicken studies gave KEDG for 40 days but don't report the dose in their abstracts.[7] There is no human dose in the literature.
Community-reported amounts for the 20 mg injectable vial mostly fall between 100 and 300 µg a day, with 200 µg once daily in 10-day courses a common version. These numbers are borrowed from other bioregulators, not derived from Testagen research. Our Testagen dosing protocol page covers the reconstitution math for the 20 mg vial, which helps with measuring accurately but is not evidence that any dose does anything.
Side Effects — What to Actually Expect
No one has collected side effect data on Testagen, so nobody can tell you what the common side effects are.
What can reasonably be said:
- Injection risks apply: redness, pain or swelling at the site, and infection if the product or technique isn't sterile.
- Product quality is the biggest unknown. Research vials are not made to drug manufacturing standards.
- Hormonal effects are unknown. Testagen is sold for testosterone, but there is no data either way on whether it affects hormones. If you are being treated for low testosterone, infertility or a pituitary condition, don't substitute it for proven care.
Regulatory & Access Status
Access status as of October 2026
Testagen is not FDA-approved for any indication and cannot be prescribed as an approved drug. One clinic on our directory lists Testagen among the peptides it offers.
In the US, Testagen is sold mainly as injectable vials labeled "research use only." That label means no one has reviewed it for safety or effectiveness in people.
Sourcing & Safety
If you decide to buy it anyway:
- Get an independent certificate of analysis (COA) from a named third-party lab, for your batch.
- Confirm the sequence. HPLC purity of at least 98% plus mass spectrometry showing Lys-Glu-Asp-Gly at about 447 Da. Because listings disagree on the sequence, this matters more for Testagen than for most peptides.
- Sterility and endotoxin testing for anything injected.
Red flags: claims that Testagen "restores Leydig cells" or raises testosterone, citations of human studies that can't be found in PubMed, and confusion with the testosterone spray of the same name.
What Makes Testagen Different
Most compounds discussed for testosterone have a clear, measured mechanism. hCG is an FDA-approved hormone whose labeled uses include selected cases of hypogonadotropic hypogonadism in men, and it acts directly on the testes. Kisspeptin-10 acts higher up, on the brain signals that tell the pituitary to release the hormones that drive the testes. Testagen has a label from its developers and no published experiment behind it.
Testagen vs. Other Compounds Discussed for Testosterone
| Parameter | Testagen | hCG | Kisspeptin-10 |
|---|---|---|---|
| What it is | 4-amino-acid bioregulator (Lys-Glu-Asp-Gly) | Glycoprotein hormone | 10-amino-acid fragment of kisspeptin |
| Proposed action | Gene regulation (unproven for testes) | Acts directly on the testes | Stimulates the brain signal upstream of the testes |
| Evidence on testosterone | None published | Established; FDA-labeled uses | Small human research studies |
| FDA status | Not approved | Approved (prescription) | Not approved |
FAQ
What is Testagen peptide?
Testagen is a synthetic tetrapeptide, lysine-glutamic acid-aspartic acid-glycine (Lys-Glu-Asp-Gly, or KEDG), from Vladimir Khavinson's peptide bioregulator program in St. Petersburg. The developers list it as a regulator of the male reproductive system. It is sold as a research peptide and is not an approved drug in the US.
What is Testagen used for?
It is marketed for testosterone support, male reproductive health and anti-aging. We found no published study in PubMed that tested Testagen on the testes, testosterone, sperm or fertility, in animals or people. The male reproductive label comes from the developers' own classification, not from published experiments.
What are the benefits of Testagen?
No benefit has been shown in humans. The published KEDG research consists of lab studies showing it can enter cell nuclei and bind DNA and histone proteins, and studies in chickens with the pituitary gland removed, where KEDG helped restore thyroid and thymus structure. None of that measures male reproductive function.
What is the Testagen dosage?
No dose has been established by any study. Community-reported amounts for the 20 mg injectable vial are most often around 100 to 300 µg a day, often around 200 µg in 10-day courses. These come from online protocols, not from research, and should not be taken as evidence that any dose works.
Is Testagen the same as Testagen TDS testosterone?
No. 'Testagen TDS-Testosterone' was a transdermal testosterone spray from a different company, tested in a skin-transfer study listed on ClinicalTrials.gov. It contains testosterone. The peptide Testagen is a four-amino-acid bioregulator with no hormone in it.
Testagen vs hCG: which raises testosterone?
hCG is an FDA-approved prescription hormone whose labeled uses include selected cases of hypogonadotropic hypogonadism in men; it acts directly on the testes. Testagen has no published evidence of raising testosterone at all. They are not comparable options.
Is Testagen FDA approved?
No. Testagen has no FDA approval for any use and is sold labeled 'for research use only.'
Related Peptides & Comparisons
If your goal is testosterone or male reproductive health, hCG and Kisspeptin-10 have real hormonal data behind them; see also our guides to hormone optimization and sexual wellness. From the same bioregulator family, Pinealon and Vilon have deeper (though still mostly animal) research, and Epitalon, Ala-Glu-Asp-Gly, differs from Testagen only in its first amino acid.
References
- Khavinson V, Linkova N, Kozhevnikova E, et al. "Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers." Int J Mol Sci. 2022;23(14):7733. PMID: 35887081
- Khavinson VK, Popovich IG, Linkova NS, et al. "Peptide Regulation of Gene Expression: A Systematic Review." Molecules. 2021;26(22):7053. PMID: 34834147
- Fedoreyeva LI, Kireev II, Khavinson VKh, et al. "Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA." Biochemistry (Mosc). 2011;76(11):1210-1219. PMID: 22117547
- Fedoreyeva LI, Smirnova TA, Kolomijtseva GY, et al. "Interaction of short peptides with FITC-labeled wheat histones and their complexes with deoxyribooligonucleotides." Biochemistry (Mosc). 2013;78(2):166-175. PMID: 23581987
- Khavinson VK, Linkova NS, Rudskoy AI, et al. "Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters." Biomolecules. 2023;13(3):552. PMID: 36979488
- Khavinson V, Linkova N, Diatlova A, et al. "Peptide Regulation of Cell Differentiation." Stem Cell Rev Rep. 2020;16(1):118-125. PMID: 31808038
- Kuznik BI, Pateyuk AV, Rusaeva NS. "Effect of tetrapeptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the structure and function of the thyroid gland in neonatally hypophysectomized chickens." Bull Exp Biol Med. 2008;145(1):104-107. PMID: 19024016
- Kuznik BI, Pateyuk AV, Rusaeva NS, et al. "Effects of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on hormonal activity and structure of the thyroid gland in hypophysectomized young chickens and old hens." Bull Exp Biol Med. 2011;150(4):495-499. PMID: 22268052
- Kuznik BI, Pateiuk AV, Rusaeva NS, et al. "Effects of hypophyseal Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly synthetic peptides on immunity, hemostasis, morphology and functions of the thyroid gland in neonatally hypophysectomized chicken and one-year-old birds." Patol Fiziol Eksp Ter. 2010;(1):14-18. PMID: 20731122
- Pateyk AV, Baranchugova LM, Rusaeva NS, et al. "Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds." Bull Exp Biol Med. 2013;154(5):681-685. PMID: 23658898
- Dobriţescu A, Samide A, Cioateră N, et al. "The Inhibitory Effect and Adsorption Properties of Testagen Peptide on Copper Surfaces in Saline Environments: An Experimental and Computational Study." Molecules. 2025;30(15):3141. PMID: 40807317
This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.




